Malini N.

Malini N. is an experienced audit and compliance professional currently serving as the VP of Corporate Audit Services at Neurocrine Biosciences since August 2022. Prior to this role, Malini held various positions at Bristol-Myers Squibb from December 2008 to August 2022, including Executive Director of Monitoring Analytics and Third Party Due Diligence, where responsibilities involved leading a global team to implement monitoring capabilities and adherence to healthcare compliance and anti-bribery regulations. Malini's career at Bristol-Myers Squibb showcased progressive advancement from Senior to Director in Audit Services. Earlier experience includes the role of Audit Senior at Deloitte & Touche from December 2006 to December 2008. Malini N. holds a Master of Science in Accounting from the University of North Carolina at Greensboro, earned between 2002 and 2004.